To subscribe to our optical e-newsletters and receive them via e-mail, click here.
We have learned much about the pathogenesis of PVR but have a lot of ground to cover to effectively treat this devastating disease.
Novel research is exploring protecting photoreceptors and the retinal pigment epithlium in multiple models of retinal disease.
The protocols for IVT injection continue to evolve as the procedure becomes one of the most-performed in U.S. medicine.
The use of stem cells to treat retinal disease has moved beyond the theoretical and proof-of-concept stages and into clinical trials.
Although many questions remain, anti-VEGF therapies for diabetic retinopathy treatment will dramatically alter the delivery of care.
Advances in optical coherence tomography reveal correlations between retinal anatomy and vision loss in several retinal diseases.
Retinopathy of prematurity screening has succeeded where other efforts in telemedicine have not and offers lessons for broader use.
As diabetes becomes more common, a large unmet need has arisen for long-acting corticsteroid implants to treat the disorder.
A look at the improvements in instrumentation and technologies that are reducing surgical risks and improving visual outcomes.
After nearly a decade of use, what the data says about the ocular and systemic safety of these increasingly used drugs.
Copyright© 2000 - 2015 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.